Mark For: REDOXOPHORE™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 76354629 |
Mark Literal Elements | REDOXOPHORE |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2005-03-10 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Lynn M. Humphreys |
Attorney Docket Number | 346392400800 |
Law Office Assigned | L50 |
Employee Name | MICHOS, JOHN E |
2002-01-03 | Application Filed |
2003-01-07 | Published |
2003-01-07 | Published for Opposition |
2004-10-02 | Abandon |
2004-10-02 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
2004-10-02 | Status: Dead/Abandoned |
2005-03-10 | Location: INTENT TO USE SECTION |
2018-07-08 | Transaction Date |
Party: | ![]() |
Address | 5301 Patrick Henry Drive Santa Clara, CALIFORNIA UNITED STATES 95054 |
Legal Entity Type | Corporation |
Legal Entity State | CALIFORNIA |
![]() | IMAGE/TIFF | 2002-01-04 |
![]() | IMAGE/TIFF | 2002-01-04 |
![]() | 2002-01-04 | |
![]() | 2002-01-04 | |
![]() | 2002-01-31 | |
![]() | 2002-02-26 | |
![]() | 2002-04-05 | |
![]() | 2002-04-23 | |
![]() | 2002-10-02 | |
![]() | 2002-10-02 | |
![]() | 2002-10-11 | |
![]() | 2002-10-23 | |
![]() | 2002-11-06 | |
![]() | 2002-12-18 | |
![]() | APPLICATION/XML | 2003-03-21 |
![]() | 2003-09-19 | |
![]() | 2003-09-19 | |
![]() | 2003-10-02 | |
![]() | 2004-03-11 | |
![]() | APPLICATION/XML,IMAGE/TIFF | 2004-03-11 |
![]() | 2004-07-12 | |
![]() | 2004-07-12 | |
![]() | 2004-08-07 | |
![]() | 2004-08-09 | |
![]() | 2005-03-09 |
(ABANDONED)
IC 001. US 001 005 006 010 026 046. G & S: chemical additives for use in the manufacture of pharmaceuticals, skin care preparations, and dietary and nutritional supplements(ABANDONED)
IC 003. US 001 004 006 050 051 052. G & S: Non-medicated skin care preparations, namely creams, lotions, cleansers, moisturizers, astringents, emollients, exfoliators, sunscreens, mousses, toners, masks, powders, foundations, cosmetics, gels, pastes, roll-ons, patches, pads, tissues, wipes, antiperspirants, deodorants, nail polish, hair conditioners, shampoos, scalp treatments(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of inflammatory and ischemic disorders, namely systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, autoimmune diabetes, skin inflammation including atopic dermatitis, contact dermatitis, allergic dermatisis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation burns, acne, oily skin, wrinkles, excessive cellulite, excessive pore size, intrinsic skin aging, photo aging, photo damage, harmful UV damage, keratinization abnormalities, alopecia, dyspigmentation inflammation due to wounds, scarring or stretch marks, loss of elasticity, skin atrophy, pigmentation control, psoriasis, inhibition of hair growth, inhibition of hair loss, stimulation of hair growth, gingivitis, central nervous system ischemia resulting from cardiac arrest, hypoxemia, transient ischemic attack, stroke or severe hypotension; cerebral ischemia including stroke, ischemic heart disease myocardial ischemia), spinal cord ischemia and paraplegia, retinal ischemia including age-related macular degeneration (ARMD), hepatic ischemia, renal ischemia, dermal ischemia, penile ischemia, pulmonary ischemia, gastric ischemia intestinal ischemia, splenic ischemia, pancreatic ischemia, skeletal muscle ischemia, ischemia associated with diabetic ulcers, gangrenous conditions, post-trauma syndrome, benign prostatic hyperplasia of hypertrophy (BPH), post prostate cancer surgery, cardiac arrest resuscitation, peripheral nerve damage or neuropathise, and dietary and nutritional supplements
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 3 |
U.S. Codes: | 001,004,006,050,051,052 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0011 | chemical additives for use in the manufacture of pharmaceuticals, skin care preparations, and dietary and nutritional supplements |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2005-03-09 | |
ABANDONMENT - NO USE STATEMENT FILED | 2005-03-09 | 47167 |
CASE FILE IN TICRS | 2004-08-10 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-07-12 | |
PAPER RECEIVED | 2004-07-12 | |
SOU EXTENSION 2 GRANTED | 2004-06-11 | |
TEAS EXTENSION RECEIVED | 2004-03-11 | |
SOU EXTENSION 2 FILED | 2004-03-11 | |
SOU EXTENSION 1 GRANTED | 2003-12-19 | |
TEAS EXTENSION RECEIVED | 2003-09-19 | |
SOU EXTENSION 1 FILED | 2003-09-19 | |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2003-04-01 | |
PUBLISHED FOR OPPOSITION | 2003-01-07 | |
NOTICE OF PUBLICATION | 2002-12-18 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-10-30 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2002-10-02 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-10-02 | |
NON-FINAL ACTION MAILED | 2002-04-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.